Literature DB >> 17129513

Indications for cardiac defibrillators in patients with congestive heart failure.

Isaac Pourati1, Lawrence Rosenthal.   

Abstract

Sudden cardiac death (SCD) is a significant cause of mortality in patients suffering from heart failure and left ventricular dysfunction. Implantable cardiac defibrillators have been shown to effectively reduce the incidence of SCD in this population. Multiple clinical trials have redefined the indications and patient profiles for their use: from secondary prevention to primary prevention of SCD. In this article, we will review the clinical trials contributing to the current practice guidelines, which include device therapy.

Entities:  

Mesh：

Year:  2006        PMID： 17129513     DOI： 10.1007/s11897-006-0022-x

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN： 1546-9530


  30 in total

1.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

2.  Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).

Authors:  Fayez Bokhari; David Newman; Mary Greene; Victoria Korley; Iqwal Mangat; Paul Dorian
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

Review 3.  New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Authors:  H Klein; A Auricchio; S Reek; C Geller
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

4.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

5.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Authors:  S J Connolly; M Gent; R S Roberts; P Dorian; D Roy; R S Sheldon; L B Mitchell; M S Green; G J Klein; B O'Brien
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

6.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

9.  Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function.

Authors:  D J Wilber; B Olshansky; J F Moran; P J Scanlon
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

10.  Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. The Pacemaker-Cardioverter-Defibrillator Investigators.

Authors:  D P Zipes; D Roberts
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.